Cleared Traditional

K960287 - HANDPIECE FOR NIDEK CV-12000 PHACO SYSTEM

K960287 is the FDA 510(k) clearance for HANDPIECE FOR NIDEK CV-12000 PHACO SYSTEM by Nidek, Inc.. It is a Class 2 Ophthalmic device (product code HQC) cleared through the Traditional 510(k) pathway after a 288-day FDA review.

K960287 · Nidek, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1996
Decision
288d
Days
Class 2
Risk

K960287 is an FDA 510(k) clearance for the HANDPIECE FOR NIDEK CV-12000 PHACO SYSTEM. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Nidek, Inc. (Fremont, US). The FDA issued a Cleared decision on November 5, 1996 after a review of 288 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Nidek, Inc. devices

Submission Details

510(k) Number K960287 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 1996
Decision Date November 05, 1996
Days to Decision 288 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
178d slower than avg
Panel avg: 110d · This submission: 288d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 112
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K960287.
WELCH ALLYN PHACO ILLUMINATOR
K971750 · Welch Allyn, Inc. · Jun 1997
STORZ MICROFLOW AND STORZ STANDARD PHACOEMULSIFICATION NEEDLES
K971439 · Storz Instrument Co. · Jun 1997
AMO DIPLOMAX/OPSYS CONSOLE
K971186 · Allergan, Inc. · Jun 1997
STORZ D7120 PHACO HANDPIECE MAINTENANCE KIT & STORZ D7125 PHACO HANDPIECE NEEDLE WRENCH
K960024 · Storz Instrument Co. · Sep 1996
AMO PRESTIGE DAY PACK (ALLERGAN, INC.)
K962402 · Allergan, Inc. · Sep 1996
STORZ D7116 MICROVIT VITRECTOMY CUTTER EXTENSION
K960003 · Storz Instrument Co. · Aug 1996